A 4-Week Study In Subjects Aged 10 To 17 Years With Bipolar I Disorder
Posted Date: Sep 9, 2020
- Investigator: Luis Patino Duran
- Type of Study: Drug
A 4-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebocontrolled Study of the Efficacy and Safety of Cariprazine in the Treatment of an Acute Manic Episode (with or without Mixed Features) Associated with Bipolar I Disorder in Pediatric Participants, Aged 10 to 17 Years.
10 To 17 Year Olds With Bipolar I Disorder
Acute Manic Episode, Bipolar I Disorder, With Or With Mixed Features
For More Information:
Raechel Cooley, B.A.